Tinea versicolor. Pityriasis versicolor
Conditions
Interventions
Intervention 1: Intervention group: will recive topical niosomal climbazol cream0.5%(will be made by pharmacy research center of Kerman university of Medical Science) to be used twice daily for 3weeks
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
12 Years to No maximum
Inclusion criteria
Inclusion criteria: A diagnosis of tinea versicolor made by the attending dermatologist who first visit patient at Afzalipour hospitals dermatology clinic Filling out and signing the written informed consent form by the patient patients age at least 12 years old Male or nonpregnant and nonbreastfeeding female
Exclusion criteria
Exclusion criteria: Any dermatologic or systemic disorders History of hypersensitivity to ketoconazole or climbazole Using systemic or topical antifungal drugs or crticosteroides during the 4weeks perior immediatly before starting the trial Using other antifungal shampoo( selenium sulfide,pyrithione zink) pregnancy or breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tinea versicolor lesion severity. Timepoint: At base line and 4,12 weeks later. Method of measurement: severity of lesion( scalling,pruritus,erythema,hyperpigmentation ,hypopigmentation). | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment side effect. Timepoint: throughout study periode and up to 3months after the start of the study. Method of measurement: history taking and physical exam. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRezvan Amiri
Kerman University of Medical Sciences
Outcome results
None listed